Neuroprotective efficiency of creatine-aminoacid complex compound in the model of ischemic stroke in rats

Introduction. According to WHO data, stroke and its consequences rank second in mortality after coronary heart disease. Hundreds of clinical trials have yielded only one tool that can be used – intravenous administration of recombinant plasminogen activator, i.e. recanalization agent. The means for effective neuroprotection, despite the huge number of studies, remain not found. The aim of the work was in vivo study of neuroprotective effect of...